行情

SELB

SELB

Selecta生物科学
NASDAQ

实时行情|Nasdaq Last Sale

1.810
-0.010
-0.55%
休市 16:00 09/20 EDT
开盘
1.810
昨收
1.820
最高
1.850
最低
1.760
成交量
32.27万
成交额
--
52周最高
16.55
52周最低
1.410
市值
8,138.29万
市盈率(TTM)
-0.8845
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SELB 新闻

  • 全球阻击电子烟
  • 新浪财经综合.1小时前
  • 欧洲最大骗税案开审 "掠夺欧洲的男人"出庭披露内幕
  • 新京报.1小时前
  • 2025年或推出AR眼镜 Facebook能否扭转行业颓势?
  • 新浪财经-自媒体综合.2小时前
  • 据悉任天堂千方百计将Switch Lite售价压低至200美元
  • 新浪财经综合.3小时前

更多

所属板块

生物技术和医学研究
+0.62%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

SELB 简况

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The Company is engaged in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its product candidates are in various stages of clinical and preclinical development. Its SVP technology encapsulates an immunomodulator in biodegradable nanoparticles to induce antigen-specific immune tolerance to mitigate the formation of anti-drug antibodies (ADAs) in response to life-sustaining biologic drugs. The Company's lead product candidate, SEL-212, is a combination of a therapeutic enzyme and its SVP technology designed to be the biologic treatment for gout.
展开

Webull提供Selecta Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。